TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
VXRT

Vaxart Inc

Healthcare · Biotechnology

0.449$ -1.1% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Vaxart Inc (VXRT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 186 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VXRT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
114 79 73 40 35 37 153 221 154 92 166 186
101 71 72 40 15 18 129 169 99 46 68 136
82 45 50 18 11 14 127 144 44 35 25 54
82 58 69 39 11 14 127 166 94 40 52 64
19 13 0.7 0.6 1.8 3.6 0.3 0.1 0.0 3.0 12 51
0.0 0.0 0.0 – 0.0 0.0 0.2 0.0 2.0 0.0 – –
0.2 0.3 0.2 0.7 1.1 0.2 1.5 6.6 16 – – –
0.0 0.0 0.0 – – – 0.0 4.5 4.5 4.5 4.5 4.5
0.0 0.0 0.0 0.0 19 17 15 11 5.0 4.3 3.6 2.8
27 9.9 27 21 24 24 29 34 43 34 107 98
27 9.0 9.2 5.9 7.5 9.2 12 11 18 14 91 87
0.2 0.2 0.4 0.2 1.7 0.8 4.8 1.8 2.3 6.5 7.1 3.0
2.8 1.9 3.9 1.4 1.0 0.9 2.1 3.9 5.5 1.6 7.0 21
0.0 0.3 0.1 39 1.9 – – – – – – –
87 70 46 19 11 13 123 188 111 58 59 88
-90 -109 -134 -164 -98 -117 -149 -219 -327 -410 -477 -460
28 32 35 3.5 63 216 487 487 487 487 487 230

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?